BioScience Health Innovations, Inc. (BHIC)
OTCMKTS · Delayed Price · Currency is USD
4.550
-0.430 (-8.63%)
At close: Aug 28, 2026

BHIC Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
534442368--
Market Cap Growth
21.76%4.32%-88.55%---
Enterprise Value
534342368--
Last Close Price
4.554.004.0036.0432.0015.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-68.40483.87---
PS Ratio
11.917.7222.82615.03--
PB Ratio
29.1429.7350.40-54370.02--
P/TBV Ratio
31.0031.4952.02---
P/OCF Ratio
-255.061815.43---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
11.807.5622.66615.10--
EV/EBIT Ratio
-59.81480.43---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.14---12.88-2.64-1.10
Net Debt / Equity Ratio
-0.25-0.45-0.79-10.03-1.97-1.00
Asset Turnover
2.144.413.829.564.37-
Inventory Turnover
3.9712.4111.174.53--
Quick Ratio
3.805.2220.350.560.400.09
Current Ratio
6.606.7821.990.930.650.09
Return on Equity (ROE)
-37.03%55.53%21.00%---
Return on Assets (ROA)
-18.28%34.83%11.24%-251.51%-442.83%-
Return on Invested Capital (ROIC)
-51.47%129.96%104.84%---
Return on Capital Employed (ROCE)
-33.40%48.70%10.40%3720.40%653.70%608.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1.23%1.46%0.21%-0.07%--
Buyback Yield / Dilution
-0.11%-4.54%-29.17%-301.99%-147.38%-